The source said that India has obtained 7.5 million doses of Moderna’s Covid19 vaccine through the global COVAX vaccine exchange program, but since no consensus has been reached on the severance clause, it is not clear when the vaccine will hit the country. Last week, the government stated that it is actively working with vaccine manufacturer Moderna to understand how to provide its vaccine in the country.
Moderna’s Covid19 vaccine received emergency use authorization from the Indian drug regulatory agency last month. “Through the global COVAX vaccine exchange program, India has received 7.5 million doses of Moderna’s Covid19 vaccine,” a source said.
However, so far, it is not clear when the injection can be carried out in India because “negotiations are still ongoing” and no consensus has been reached on compensation,” a source said. Regarding the availability of Moderna vaccines in the country, NITI member Dr. Aayog (Health) V K Paul recently stated that the government is actively working with Moderna to understand how to import and provide their vaccines in the country.
“… They come and go (negotiations) on the details of the contract. The discussion is not over yet. We are working hard to achieve this as soon as possible. Now we hope to hear from them at any time. Currently, they must respond to some of the points we made. We will keep moving forward, “he said on Friday. According to the sources, the Indian government has proposed certain conditions to end the contract with compensation clauses and has sent them to the US pharmaceutical companies for their reading.